946P Hepatic artery infusion chemotherapy (HAIC) combined with apatinib and camrelizumab for hepatocellular carcinoma (HCC) in BCLC stage C: A prospective, single-arm, phase II trial (TRIPLET study)

Autor:	T-Q. Zhang, P-H. Wu, J-B. Li, Y-K. Gu, M-X. Zuo, Z-J. Geng, Z-L. Huang
Rok vydání:	2021
Předmět:	Chemotherapy medicine.medical_specialty business.industry medicine.medical_treatment Hematology medicine.disease Gastroenterology BCLC Stage chemistry.chemical_compound Artery infusion Oncology chemistry Hepatocellular carcinoma Internal medicine Medicine Apatinib business
Zdroj:	Annals of Oncology. 32:S825
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::bca4bb96415f118a037abc299bbea484 https://doi.org/10.1016/j.annonc.2021.08.166 Zobrazit plný text záznamu